News

Stevens Point
wsau. com > 07/09/2026 > bausch-to-stop-glaucoma-eye-drop-development-after-trial-miss

Bausch to stop glaucoma eye drop development after trial miss

1+ hour, 14+ min ago  (167+ words) July 9 (Reuters) " Bausch + Lomb said on Thursday its glaucoma eye drop had missed "the main goal in a "mid-stage trial of replicating visual function improvements observed in a smaller study. The company said it will discontinue "development "of the eye…...

Symbols: tsx:blco
WBIW
wbiw. com > 07/09/2026 > beyond-the-lungs-how-smoking-silently-threatens-your-eyesight

Beyond the Lungs: How smoking silently threatens your eyesight

8+ hour, 52+ min ago  (217+ words) INDIANA " While most people associate cigarette smoking with cardiovascular disease and lung damage, eye health experts warn that tobacco smoke poses an equally severe'yet often overlooked'threat to vision. Cigarette smoke introduces heavy metals, chemical toxins, and free radicals directly into…...

Symbols: d05.S0,u11.S0,z74.S0,m03.S0,blz.si,575.S0
Center for Biosimilars
centerforbiosimilars. com > view > anti-vegf-biosimilars-match-reference-drug-in-indian-retinal-disease-care

Anti-VEGF Biosimilars Match Reference Drug in Indian Retinal Disease Care

6+ hour, 59+ min ago  (242+ words) Biosimilar anti-VEGF agents matched the reference ranibizumab in vision outcomes and safety across retinal diseases in India, at a lower cost. Biosimilar anti-VEGF agents matched reference ranibizumab in vision outcomes and safety across retinal diseases in India, at substantially lower…...

Symbols: nasdaq:ocul
Eyewire+
eyewire. news > news > biocon-announces-peer-reviewed-data-supporting-yesafili-in-diabetic-macular-edema

Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema

7+ hour, 36+ min ago  (270+ words) Biocon announced the publication of two peer-reviewed studies from the phase 3 INSIGHT program evaluating MYL-1701 P, its aflibercept biosimilar approved by the FDA as Yesafili (aflibercept-jbvf), for the treatment of diabetic macular edema. 1, 2 The first study, published June 29, 2026, reported findings…...

Symbols: nasdaq:ocs
Huff Post UK
huffingtonpost. co. uk > entry > milia-eye-condition-explained_uk_6a4f575ce4b04b52a93e695a

So THAT's What Those Tiny Bumps Near Your Eye Mean

9+ hour, 37+ min ago  (502+ words) They're common in newborns but can occur in adults too. We've written about dishydrotic eczema, or pompholyx, before at Huff Post UK. That shows up as tiny, incredibly itchy, usually flesh-coloured bumps on your hands and feet. It should always…...

Symbols: otc:over
Contract Pharma
contractpharma. com > breaking-news > boehringer-ingelheim-biomed-x-form-eye-health-research-team

Boehringer Ingelheim, Bio Med X Form Eye Health Research Team

9+ hour, 37+ min ago  (335+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...

Symbols: nasdaq:ocul
Medical Dialogues
medicaldialogues. in > ophthalmology > news > dexmedetomidine-enhances-onset-and-prolongs-peribulbar-block-in-eye-surgery-systematic-review-174436

Dexmedetomidine Enhances Onset and Prolongs Peribulbar Block in Eye Surgery: Systematic Review

7+ hour, 47+ min ago  (277+ words) A recent systematic review published in the Delhi Journal of Ophthalmology in June 2026 highlights an exciting advancement in regional ophthalmic blocks: using dexmedetomidine as a peribulbar adjuvant rapidly accelerates the onset and significantly extends the duration of ocular sensory and…...

Symbols: nasdaq:vtrs
ROI-NJ
roi-nj. com-nj. com

Atlantic Eye adds Frieman Ophthalmology

7+ hour, 48+ min ago  (174+ words) Ophthalmologists Dr. Lawrence Frieman (left) and Dr. Brett Frieman (right). - courtesy Atlantic Eye Atlantic Eye, a provider of comprehensive eye care services, said Frieman Ophthalmology is now part of Atlantic Eye, adding Dr. Lawrence Frieman and Dr. Brett Frieman to…...

Symbols: btc-usd
@revoptom
reviewofoptometry. com > article > brain-care-score-a-new-tool-that-can-predict-agerelated-eye-disease-risk

Brain Care Score: A New Tool That Can Predict Age-related Eye Disease Risk

12+ hour, 33+ min ago  (159+ words) A total of 382, 221 participants without cataract, glaucoma or AMD at baseline were included in the study. The researchers used statistical analysis to estimate associations between baseline Brain Care Score and incident cataract, glaucoma and AMD. They used polygenic risk scores…...

Symbols: wow.ax,cba.ax,d05.S0,u11.S0,z74.S0,m03.S0
Clarity News
clarity-news. com

Primary eye care support ready to transform glaucoma care

11+ hour, 40+ min ago  (620+ words) Optometry sector welcomes convergence of views on enhanced detection and referral filtering in the community but calls for adequate funding The eye care sector is marking Glaucoma Awareness Week 2026 with renewed focus following the recent publication of NHS guidance higlighting…...

Symbols: btc-usd